Recombinant Monosiga brevicollis Branched-chain-amino-acid aminotransferase (37018)

What is Monosiga brevicollis and why is it significant for evolutionary research?

Monosiga brevicollis is a choanoflagellate that is considered one of the closest living unicellular relatives of metazoans (animals). This organism has significant evolutionary importance as it provides insights into the transition from unicellular to multicellular life forms. The genome of M. brevicollis contains a surprisingly high number and diversity of tyrosine kinases, tyrosine phosphatases, and phosphotyrosine-binding domains, many with domain combinations not observed in multicellular organisms . M. brevicollis has become an established model system for studying the evolution of animal multicellularity, cell differentiation, and immune responses . Recent studies have also demonstrated that M. brevicollis expresses STING, which functions in antibacterial immunity, similar to its role in animal immune systems .

What is Branched-chain-amino-acid aminotransferase and what is its biological function?

Branched-chain-amino-acid aminotransferase (BCAT) is an enzyme that catalyzes the reversible transamination of branched-chain amino acids (BCAAs) - leucine, isoleucine, and valine - to their corresponding α-keto acids, while converting α-ketoglutarate to glutamate. This reaction represents the final step in BCAA biosynthesis and the initial step in BCAA catabolism. In M. brevicollis, this enzyme is part of the metabolic machinery that may provide insights into the evolution of amino acid metabolism from unicellular to multicellular organisms.

How does M. brevicollis BCAT compare structurally to BCATs from other organisms?

While the search results don't provide specific structural information about M. brevicollis BCAT, typical BCATs contain a catalytic domain with a conserved pyridoxal-5'-phosphate (PLP) binding site. Based on general BCAT knowledge and the evolutionary position of M. brevicollis, we can hypothesize that its BCAT likely shares structural similarities with both prokaryotic and eukaryotic homologs, potentially displaying unique features that reflect its evolutionary position. Researchers investigating structural aspects should perform comparative sequence analysis with BCATs from various evolutionary lineages, followed by 3D structure prediction or determination.

What are the optimal conditions for expressing recombinant M. brevicollis BCAT?

For recombinant expression of M. brevicollis proteins, researchers can follow protocols similar to those used for expressing other M. brevicollis proteins. Based on methodologies described for other M. brevicollis proteins in the search results, expression systems might include:

• Insect cell expression: Sf9 cells using a baculovirus expression system, as demonstrated for HMTK1

• E. coli expression systems: Particularly for isolated domains, as shown with the PTB domain of HMTK1

• Mammalian cell expression: Using vectors such as p3XFLAG-CMV, as was successful for HMTK1

The optimal expression conditions would need to be empirically determined by testing different expression systems, temperature conditions, induction protocols, and purification strategies.

What purification strategies are most effective for recombinant M. brevicollis BCAT?

Based on the purification methods used for other M. brevicollis recombinant proteins, effective strategies may include:

• Affinity chromatography: Using His-tag purification with nickel-nitrilotriacetic acid resin, as was successful for HMTK1

• Size-exclusion chromatography: For further purification and buffer exchange

• Ion-exchange chromatography: To separate based on charge differences

The purification protocol should be optimized based on the specific construct design, including any affinity tags incorporated into the recombinant protein. Researchers should verify purification using SDS-PAGE and Western blotting before proceeding to enzymatic assays.

How can I accurately measure the enzymatic activity of recombinant M. brevicollis BCAT?

BCAT activity can be measured using several established methods:

• Spectrophotometric assays: Monitoring the production of α-keto acids at 280 nm

• Coupled enzyme assays: Using glutamate dehydrogenase to couple BCAT activity to NADH oxidation, which can be monitored at 340 nm

• HPLC analysis: Quantifying the formation of keto acids or the consumption of amino acids

• Radiometric assays: Using 14C-labeled amino acids and measuring the transfer of radioactivity

A standardized assay protocol for M. brevicollis BCAT might include:

Reactions should be incubated at 30°C and stopped at various time points to establish linear reaction rates.

How can recombinant M. brevicollis BCAT contribute to understanding the evolution of metabolic pathways?

M. brevicollis occupies a critical phylogenetic position as one of the closest unicellular relatives of metazoans. Studying its BCAT enzyme can reveal:

• Evolutionary transitions in amino acid metabolism between unicellular and multicellular organisms

• Conservation or divergence of enzyme mechanism, specificity, and regulation

• Insights into the co-evolution of metabolic pathways with multicellularity

Researchers can use comparative enzymatic studies between M. brevicollis BCAT and homologs from various taxonomic groups to trace the evolution of BCAA metabolism. This would involve comparing kinetic parameters, substrate specificity, and regulatory mechanisms across evolutionary lineages.

What techniques can be used to investigate the subcellular localization of BCAT in M. brevicollis?

Several approaches can be employed to determine the subcellular localization:

• Immunofluorescence microscopy using antibodies against the recombinant BCAT

• Expression of GFP-tagged BCAT in M. brevicollis cells

• Subcellular fractionation followed by Western blotting

• Bioinformatic prediction of localization signals within the protein sequence

Understanding the subcellular localization could provide insights into metabolic compartmentalization in this evolutionary important organism. For microscopy studies, protocols similar to those established for studying other M. brevicollis proteins can be adapted.

How might BCAT function relate to the immune response mechanisms in M. brevicollis?

Recent research has demonstrated that M. brevicollis possesses immune response mechanisms, including STING-mediated responses to bacterial pathogens like Pseudomonas aeruginosa . While direct evidence linking BCAT to immune responses is not provided in the search results, several hypothetical connections can be proposed for investigation:

• Branched-chain amino acid metabolism might influence cellular stress responses during pathogen exposure

• BCAT activity could affect the availability of amino acids necessary for immune-related protein synthesis

• Metabolic changes during immune responses might involve altered BCAT regulation

RNA-seq analysis of M. brevicollis exposed to P. aeruginosa revealed 674 upregulated genes involved in stress response, endocytosis, and metabolism . Further studies could investigate whether BCAT expression or activity changes during immune challenges.

How does the substrate specificity of M. brevicollis BCAT compare to homologs from other species?

This question requires empirical investigation, as the search results don't provide direct information on M. brevicollis BCAT substrate specificity. A comprehensive comparative analysis would include:

• Kinetic analysis using various branched-chain amino acids (leucine, isoleucine, valine) as substrates

• Testing non-canonical amino acid substrates to determine specificity breadth

• Comparing kinetic parameters (Km, kcat, catalytic efficiency) with homologs from bacteria, fungi, plants, and animals

Researchers could present comparative data in a table format:

What structural features distinguish M. brevicollis BCAT from its homologs in other organisms?

Analysis of the primary sequence of M. brevicollis BCAT could reveal:

• Conservation of catalytic residues across evolutionary lineages

• Unique insertions or deletions that might confer functional specialization

• Potential regulatory domains or motifs specific to choanoflagellates

Researchers should perform multiple sequence alignments with BCATs from diverse organisms, followed by homology modeling to predict structural features. X-ray crystallography or cryo-EM studies would provide definitive structural information.

How does the regulation of BCAT activity in M. brevicollis compare to regulatory mechanisms in metazoans?

This advanced research question requires investigation of:

• Allosteric regulation by metabolites

• Post-translational modifications affecting enzyme activity

• Transcriptional and translational regulation under different conditions

Studies in other organisms have shown that BCAT activity can be regulated by redox status, substrate availability, and cellular metabolic state. Research into M. brevicollis BCAT regulation could reveal evolutionary precursors to the complex regulatory networks in metazoans.

What are common challenges in expressing active recombinant M. brevicollis BCAT and how can they be addressed?

Potential challenges include:

• Protein insolubility: This can be addressed by optimizing expression temperature (often lowering to 16-18°C), using solubility-enhancing fusion tags (MBP, SUMO), or employing specialized E. coli strains.

• Low yield: Researchers might optimize codon usage for the expression host, test different promoter systems, or scale up culture volumes.

• Loss of activity during purification: Consider adding stabilizing agents (glycerol, reducing agents), optimizing buffer conditions, and minimizing purification steps.

• Incorrect folding: Chaperone co-expression or in vitro refolding protocols might help recover active enzyme.

From the search results, we know that researchers successfully expressed other M. brevicollis proteins in Sf9 insect cells , which might provide a good starting point for expressing challenging proteins.

How can I design rigorous controls for experiments involving recombinant M. brevicollis BCAT?

Essential controls include:

• Enzymatic assays:

  • Negative controls: Heat-inactivated enzyme, reaction without substrate, reaction without enzyme

  • Positive controls: Well-characterized BCAT from another species

  • Specificity controls: Testing non-BCAA substrates

• Expression and purification:

  • Empty vector controls processed identically to verify background

  • Activity comparison between different purification batches to ensure consistency

• Localization studies:

  • Secondary antibody-only controls

  • Untransfected cell controls

  • Known subcellular markers for colocalization

What are the best approaches to investigate potential interaction partners of M. brevicollis BCAT?

To identify protein-protein interactions, researchers could employ:

• Affinity purification coupled with mass spectrometry (AP-MS)

• Yeast two-hybrid screening

• Proximity-dependent biotin identification (BioID)

• Co-immunoprecipitation followed by Western blotting for suspected partners

• Fluorescence resonance energy transfer (FRET) or bimolecular fluorescence complementation (BiFC)

Studies of the M. brevicollis interactome have revealed unique protein domain combinations and interaction networks . Investigation of BCAT interactions could provide insights into its regulation and metabolic integration in this evolutionarily significant organism.